The serotonin system and spiritual experiences

American Journal of Psychiatry

Volumn 160, Issue 11, 2003, Pages 1965-1969

  Borg, Jacqueline ^a   Andrée, Bengt ^a   Soderstrom, Henrik ^a   Farde, Lars ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; CHARACTER; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERSONALITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; RELIGION; SEROTONINERGIC SYSTEM; TEMPERAMENT;

ADULT; BRAIN; CHARACTER; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEOCORTEX; PERSONALITY; PERSONALITY ASSESSMENT; PERSONALITY INVENTORY; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SPIRITUALITY; TEMPERAMENT; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1642436793     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.11.1965     Document Type: Article

References (30)

1. Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002; 71:533-554
2. 1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 1998; 8:426-440
3. 11C]raclopride in man. Synapse 1995; 20:200-208
4. Laine TP, Ahonen A, Rasanen P, Tiihonen JJ: Dopamine transporter density and novelty seeking among alcoholics Addict Disord 2001; 20:91-96
5. Farde L, Gustavsson JP, Jonsson E: D2 dopamine receptors and personality traits (letter). Nature 1997; 385:590
6. Rabiner EA, Messa C, Sargent PA, Husted-Kjaer K, Montgomery A, Lawrence AD, Bench CJ, Gunn RN, Cowen P, Grasby PM: A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. Neuroimage 2002; 15:620-632
7. Cloninger CR, Svrakic DM, Przybeck TR: A psychobiological model of temperament and character. Arch Gen Psychiatry 1993; 50:975-990
8. Andrée B, Halldin C, Pike VW, Gunn RN, Olsson H, Farde L: The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain. J Nucl Med 2002; 43:292-303
9. 1A receptors in the human brain confirmed with positron emission tomography. Psychopharmacology (Berl) 1999; 144:303-305
10. Bergstrom M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L: Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist To mogr 1981; 5:136-141
11. 11C]way-100635. Brain Res 1997; 745:96-108
12. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, Heiss WD: The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994; 18:110-118
13. Brandstrom S, Schlette P, Przybeck TR, Lundberg M, Forsgren T, Sigvardsson S, Nylander PO, Nilsson LG, Cloninger RC, Adolfsson R: Swedish normative data on personality using the Temperament and Character Inventory. Compr Psychiatry 1998; 39:122-128
14. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ: A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984; 15:217-227
15. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD: The Temperament and Character Inventory: A Guide to Its Development and Use. St Louis, Washington University Center for Psychobiology of Personality, 1994
16. Glennon RA: Do classical hallucinogens act as 5-HT2 agonists or antagonists? Neuropsychopharmacology 1990; 3:509-517
17. Aghajanian GK, Marek GJ: Serotonin and hallucinogens. Neuropsychopharmacology 1999; 21(2 suppl):16S-23S
18. Freese TE, Miotto K, Reback CJ: The effects and consequences of selected club drugs. J Subst Abuse Treat 2002; 23:151-156
19. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB: Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 2002; 99:11934-11939
20. Koe BK, Weissman A: p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 1966; 154:499-516
21. Albert DJ, Walsh ML: Neural systems and the inhibitory modulation of agonistic behavior: a comparison of mammalian species. Neurosci Biobehav Rev 1984; 8:5-24
22. Svrakic DM, Whitehead C, Przybeck TR, Cloninger CR: Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch Gen Psychiatry 1993; 50:991-999
23. Soderstrom H, Rastam M, Gillberg C: Temperament and character in adults with Asperger syndrome. Autism 2002; 6:287-297
24. Brewerton TD: Hyperreligiosity in psychotic disorders. J Nerv Ment Dis 1994; 182:302-304
25. Kirk KM, Eaves LJ, Martin NG: Self-transcendence as a measure of spirituality in a sample of older Australian twins. Twin Res 1999; 2:81-87
26. Brandstrom S, Richter J, Przybeck TR: Distributions by age and sex of the dimensions of temperament and character inventory in a cross-cultural perspective among Sweden, Germany, and the USA. Psychol Rep 2001; 89:747-758
27. 11C]WAY-100635 and PET. Neuropsychopharmacology 2001; 24:522-530
28. Cidis Meltzer C, Drevets WC, Price JC, Mathis CA, Lopresti B, Greer PJ, Villemagne VL, Holt D, Mason NS, Houck PR, Reynolds CF III, DeKosky ST: Gender-specific aging effects on the serotonin 1A receptor. Brain Res 2001; 895:9-17
29. Bouchard TJ Jr, Lykken DT, McGue M, Segal NL, Tellegen A: Sources of human psychological differences: the Minnesota Study of Twins Reared Apart. Science 1990; 250:223-228
30. Veenstra-VanderWeele J, Anderson GM, Cook EH Jr: Pharmacogenetics and the serotonin system: initial studies and future directions. Eur J Pharmacol 2000; 410:165-181